Published in J Neuroinflammation on April 08, 2014
New insights into the impact of neuro-inflammation in rheumatoid arthritis. Front Neurosci (2014) 0.86
Peripheral challenge with a viral mimic upregulates expression of the complement genes in the hippocampus. J Neuroimmunol (2015) 0.81
A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid Arthritis. Medicine (Baltimore) (2015) 0.80
Defining the Microglia Response during the Time Course of Chronic Neurodegeneration. J Virol (2015) 0.80
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochim Biophys Acta (2016) 0.80
Fatigue in chronic inflammation - a link to pain pathways. Arthritis Res Ther (2015) 0.79
Corticotropin-Releasing Factor and Toll-Like Receptor Gene Expression Is Associated with Low-Grade Inflammation in Irritable Bowel Syndrome Patients with Depression. Gastroenterol Res Pract (2016) 0.78
TLR7-mediated skin inflammation remotely triggers chemokine expression and leukocyte accumulation in the brain. J Neuroinflammation (2016) 0.77
Cerebral Response to Peripheral Challenge with a Viral Mimetic. Neurochem Res (2015) 0.76
Virus Infections on Prion Diseased Mice Exacerbate Inflammatory Microglial Response. Oxid Med Cell Longev (2016) 0.75
Brain Injury Alters Volatile Metabolome. Chem Senses (2016) 0.75
Activation of innate immune genes in caprine blood leukocytes after systemic endotoxin challenge. BMC Vet Res (2016) 0.75
Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2017) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol (2005) 9.70
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature (2007) 7.34
Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol (2009) 4.63
Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med (2001) 4.39
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26
Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med (2002) 2.67
Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun (2001) 2.51
Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron (2010) 2.24
Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry (2003) 2.13
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut (2007) 1.75
Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A (2007) 1.62
Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol (1997) 1.52
Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J Exp Med (1996) 1.51
Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience (1998) 1.51
Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J Neurochem (2001) 1.41
Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun (2009) 1.41
Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience (1999) 1.40
Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun (2010) 1.33
Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology (1994) 1.31
In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J Neuroimmunol (2005) 1.23
Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol (2011) 1.19
A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, [corrected] TNF-α and IL-6 challenges in C57BL/6 mice. PLoS One (2013) 1.08
Depression from interferon therapy in patients with hepatitis C. Am J Psychiatry (1999) 1.03
Differential expression of cytokines in the brain and serum during endotoxin tolerance. J Neuroimmunol (2005) 1.01
Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke (2012) 1.00
Peripheral lipopolysaccharide stimulation induces interleukin-1 beta messenger RNA in rat brain microglial cells. Neuroscience (1995) 0.98
Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology (1996) 0.97
Peripheral challenge with double-stranded RNA elicits global up-regulation of cytokine gene expression in the brain. J Neurosci Res (2009) 0.89
Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the Toll-like receptor 7 agonist imiquimod. Neuroscience (2011) 0.84
Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun (1995) 0.83
The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol (2005) 2.98
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol (2008) 2.08
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell (2004) 1.60
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest (2007) 1.46
Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med (2008) 1.34
Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources. Stem Cells (2007) 1.24
Immune regulation by atypical chemokine receptors. Nat Rev Immunol (2013) 1.17
The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med (2006) 1.15
A murine specific expansion of the Rhox cluster involved in embryonic stem cell biology is under natural selection. BMC Genomics (2006) 1.12
Purification and biochemical characterization of the D6 chemokine receptor. Biochem J (2004) 1.07
Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochem Biophys Res Commun (2010) 1.06
Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J Immunol (2006) 1.04
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.99
Multiple roles for the C-terminal tail of the chemokine scavenger D6. J Biol Chem (2008) 0.99
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.97
A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood (2009) 0.95
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. Ann Rheum Dis (2011) 0.95
D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood (2011) 0.93
Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol (2010) 0.92
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am J Pathol (2012) 0.90
Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha. Blood (2002) 0.90
The chemokine ESkine/CCL27 displays novel modes of intracrine and paracrine function. J Immunol (2002) 0.90
An analysis of the function and expression of D6 on lymphatic endothelial cells. Blood (2013) 0.90
D6: the 'crowd controller' at the immune gateway. Trends Immunol (2012) 0.89
Structure-function dissection of D6, an atypical scavenger receptor. Methods Enzymol (2009) 0.89
Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD. Respir Res (2013) 0.86
Cloning and characterization of Ehox, a novel homeobox gene essential for embryonic stem cell differentiation. J Biol Chem (2002) 0.84
Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice. J Biol Chem (2013) 0.80
CCL27/PESKY: a novel paradigm for chemokine function. Expert Opin Biol Ther (2003) 0.80
Acute inflammatory response to cobalt chromium orthopaedic wear debris in a rodent air-pouch model. J R Soc Interface (2012) 0.80
Dimeric integrin alpha5beta1 ligands confer morphological and differentiation responses to murine embryonic stem cells. Biochem Biophys Res Commun (2009) 0.80
A310 helical turn is essential for the proliferation-inhibiting properties of macrophage inflammatory protein-1 alpha (CCL3). Blood (2005) 0.79
The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding. J Biol Chem (2014) 0.77
Flow cytometry applications for the analysis of chemokine receptor expression and function. Cytometry A (2014) 0.76
Corrigendum: CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses. Sci Rep (2017) 0.75